Cargando…

The influence of interval between doses on response to vaccines

Detalles Bibliográficos
Autores principales:	Rodrigues, Charlene M.C., Plotkin, Stanley A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580840/ https://www.ncbi.nlm.nih.gov/pubmed/34774357 http://dx.doi.org/10.1016/j.vaccine.2021.10.050

Ejemplares similares

Sang Froid in a time of trouble: is a vaccine against HIV possible?
por: Plotkin, Stanley A
Publicado: (2009)

Impact of Vaccines; Health, Economic and Social Perspectives
por: Rodrigues, Charlene M. C., et al.
Publicado: (2020)

The scourge of vaccine falsification
por: Saliou, Pierre, et al.
Publicado: (2022)

Whither vaccines?
por: Rodrigues, Charlene M.C., et al.
Publicado: (2017)

Response to the 2009 pandemic: Effect on influenza control in wealthy and poor countries
por: Monto, Arnold S., et al.
Publicado: (2011)

Polio eradication vaccine investment: how do we ensure polio vaccines are available to keep the world polio-free after transmission of wild poliovirus (wPV) has been interrupted?
por: Batson, Amie, et al.
Publicado: (2021)

In Memoriam: Dr H. Fred Clark (1937–2012)
por: Offit, Paul, et al.
Publicado: (2012)

Deciphering Crosstalk Circuits in Non-small Cell Lung Cancers with an Increasing Interval Length of Low Dose CT Screening
por: Rosell, Rafael, et al.
Publicado: (2015)

Improved immunologic response to COVID‐19 vaccine with prolonged dosing interval in haemodialysis patients
por: Haarhaus, Mathias, et al.
Publicado: (2022)

Ethical and policy considerations for COVID-19 vaccination modalities: delayed second dose, fractional dose, mixed vaccines
por: Wolff, Jonathan, et al.
Publicado: (2021)

High-Dose, Extended-Interval Colistin Administration in Critically Ill Patients: Is This the Right Dosing Strategy? A Preliminary Study
por: Dalfino, Lidia, et al.
Publicado: (2012)

Carrier-Induced Hyporesponsiveness to Pneumococcal Conjugate Vaccines: Unraveling the Influence of Serotypes, Timing, and Previous Vaccine Dose
por: Dagan, Ron, et al.
Publicado: (2020)

Making more COVID-19 vaccines available to address global needs: Considerations and a framework for their evaluation
por: Krause, Philip R, et al.
Publicado: (2022)

Maneuvering in the Interval: Reflections on Immanent Entanglements
por: Wiltse, Heather
Publicado: (2021)

Is hepatitis B birth dose vaccine needed in Africa?
por: Tamandjou, Cynthia Raissa, et al.
Publicado: (2017)

The world needs to prepare now to prevent polio resurgence post eradication
por: Batson, Amie, et al.
Publicado: (2022)

A third dose of mRNA-1273 vaccine improves SARS-CoV-2 immunity in HCT recipients with low antibody response after 2 doses
por: Pettini, Elena, et al.
Publicado: (2022)

What Role for Biologically Based Dose–Response Models in Estimating Low-Dose Risk?
por: Crump, Kenny S., et al.
Publicado: (2010)

Ophthalmological Considerations for COVID-19 Vaccination in Patients with Inflammatory Eye Diseases and Autoimmune Disorders
por: Chau, Charlene Y. C., et al.
Publicado: (2021)

Vaccines: past, present and future
por: Plotkin, Stanley A
Publicado: (2005)

Saturation time of exposure interval for cross-neutralization response to SARS-CoV-2: Implications for vaccine dose interval
por: Miyamoto, Sho, et al.
Publicado: (2023)

Is a single COVID-19 vaccine dose enough in convalescents ?
por: Focosi, Daniele, et al.
Publicado: (2021)

Commentary: “The vaccine Selfie” and its influence on COVID-19 vaccine acceptance
por: Markovitz, Netana H., et al.
Publicado: (2022)

Secukinumab without the initial loading dose in the treatment of plaque‐type psoriasis – a simplified dosing regimen at the expense of efficacy?
por: Aichelburg, M.C., et al.
Publicado: (2019)

Vaccines for epidemic infections and the role of CEPI
por: Plotkin, Stanley A.
Publicado: (2017)

Nonmonotonic Dose–Response Curves Occur in Dose Ranges That Are Relevant to Regulatory Decision-Making
por: Hill, Corinne E., et al.
Publicado: (2018)

Recent updates on correlates of vaccine-induced protection
por: Plotkin, Stanley A.
Publicado: (2023)

Vaccination after prior COVID-19 infection: Implications for dose sparing and booster shots
por: Kent, Stephen J, et al.
Publicado: (2021)

The (mis)use of overlap of confidence intervals to assess effect modification
por: Knol, Mirjam J., et al.
Publicado: (2011)

Sessile Serrated Adenoma; the Hard-to-Catch Culprit of Interval Cancer
por: Shin, Suk Pyo
Publicado: (2017)

Improving childhood vaccination coverage rates: the case of fourth dose of DTaP
por: Clark, Sarah J., et al.
Publicado: (2020)

The one-dose schedule opens the door to rapid scale-up of HPV vaccination
por: Zou, Zhuoru, et al.
Publicado: (2023)

The potential risks of delaying the second vaccine dose during the SARS-CoV-2 pandemic
por: Humphreys, I R, et al.
Publicado: (2021)

The long-term antibody response after SARS-CoV-2 prime-boost vaccination in healthy individuals. The positive influence of extended between-dose intervals and heterologous schedule
por: Naidich, Gretel, et al.
Publicado: (2023)

Dose response of ACE inhibitors: implications of the SECURE trial
por: Lonn, Eva
Publicado: (2001)

The dose-response relationship for cardiovascular disease is not necessarily linear
por: Schneider, Uwe, et al.
Publicado: (2017)

Importance of the Size of Adenomatous Polyps in Determining Appropriate Colonoscopic Surveillance Intervals
por: Koo, Hoon Sup, et al.
Publicado: (2018)

A shortened interval between vaccinations with the trivalent inactivated influenza vaccine increases responsiveness in the aged
por: Kannan, Senthil, et al.
Publicado: (2015)

Low-dose single-shot COVID-19 mRNA vaccines lie ahead
por: Sanders, Niek N.
Publicado: (2021)

mSphere of Influence: Pertussis Vaccination and Antibodies in Mothers and Infants
por: Portillo, Susana
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_un0sr9pmtkkr4ndktme7394o8g